FDA NDC Directory · JSON-LD · Markdown

Orphenadrine Citrate

NDC 0591-3222 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA084779
Dosage form / routeINJECTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsORPHENADRINE CITRATE (30 mg/mL)
Marketing started20100708
Package count1

External sources

Source: openFDA. Public-domain (CC0).